Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2022 Jun 27

PMID 35756032

Authors

Mi Nguyen-Tra Le

Miki Kawada-Matsuo

Hitoshi Komatsuzawa

Affiliations

Soon will be listed here.

Abstract

Antibiotics play a vital role in saving millions of lives from fatal infections; however, the inappropriate use of antibiotics has led to the emergence and propagation of drug resistance worldwide. Multidrug-resistant bacteria represent a significant challenge to treating infections due to the limitation of available antibiotics, necessitating the investigation of alternative treatments for combating these superbugs. Under such circumstances, antimicrobial peptides (AMPs), including human-derived AMPs and bacteria-derived AMPs (so-called bacteriocins), are considered potential therapeutic drugs owing to their high efficacy against infectious bacteria and the poor ability of these microorganisms to develop resistance to them. Several staphylococcal species including , , , and are commensal bacteria and known to cause many opportunistic infectious diseases. Methicillin-resistant , especially methicillin-resistant (MRSA), are of particular concern among the critical multidrug-resistant infectious Gram-positive pathogens. Within the past decade, studies have reported promising AMPs that are effective against MRSA and other methicillin-resistant . This review discusses the sources and mechanisms of AMPs against staphylococcal species, as well as their potential to become chemotherapies for clinical infections caused by multidrug-resistant staphylococci.

Citing Articles

The Role and Mechanisms of Antimicrobial Peptides in Overcoming Multidrug-Resistant Bacteria.

Yang J, Zhang J, Feng Z, Ma Y Molecules. 2025; 30(1.

PMID: 39795190 PMC: 11721820. DOI: 10.3390/molecules30010128.

Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management.

Subbarayudu S, Namasivayam S, Arockiaraj J Curr Microbiol. 2024; 81(10):346.

PMID: 39240286 DOI: 10.1007/s00284-024-03875-7.

Pharmacological composition based on bacteriocinnisin in experiments and .

Isakova M, Oparina O, Belousov A, Lysova Y Open Vet J. 2024; 14(6):1370-1383.

PMID: 39055763 PMC: 11268911. DOI: 10.5455/OVJ.2024.v14.i6.5.

The two-component regulatory systems GraRS and SrrAB mediate susceptibility to Pep5 produced by clinical isolate of .

Suzuki Y, Kawada-Matsuo M, Le M, Eng S, Hisatsune J, Sugai M Appl Environ Microbiol. 2024; 90(7):e0030024.

PMID: 38832774 PMC: 11267926. DOI: 10.1128/aem.00300-24.

Ursoricin, a bacteriocin of , has potent activity against methicillin-resistant and vancomycin-resistant enterococci.

Wang C, Le M, Kawada-Matsuo M, Hisatsune J, Sugawara Y, Arai C Appl Environ Microbiol. 2024; 90(6):e0016224.

PMID: 38775468 PMC: 11218630. DOI: 10.1128/aem.00162-24.

References

Du H, Puri S, McCall A, Norris H, Russo T, Edgerton M . Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens. Front Cell Infect Microbiol. 2017; 7:41. PMC: 5309243. DOI: 10.3389/fcimb.2017.00041. View

Rothstein D, Spacciapoli P, Tran L, Xu T, ROBERTS F, Dalla Serra M . Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother. 2001; 45(5):1367-73. PMC: 90475. DOI: 10.1128/AAC.45.5.1367-1373.2001. View

Huang Q, Yu H, Liu G, Huang X, Zhang L, Zhou Y . Comparison of the effects of human β-defensin 3, vancomycin, and clindamycin on Staphylococcus aureus biofilm formation. Orthopedics. 2012; 35(1):e53-60. DOI: 10.3928/01477447-20111122-11. View

Breukink E, de Kruijff B . The lantibiotic nisin, a special case or not?. Biochim Biophys Acta. 1999; 1462(1-2):223-34. DOI: 10.1016/s0005-2736(99)00208-4. View

Peschel A, Otto M, JACK R, Kalbacher H, Jung G, Gotz F . Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem. 1999; 274(13):8405-10. DOI: 10.1074/jbc.274.13.8405. View

Hasper H, Kramer N, Smith J, Hillman J, Zachariah C, Kuipers O . An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science. 2006; 313(5793):1636-7. DOI: 10.1126/science.1129818. View

Foster T . The Staphylococcus aureus "superbug". J Clin Invest. 2004; 114(12):1693-6. PMC: 535074. DOI: 10.1172/JCI23825. View

Gross E, Morell J . The structure of nisin. J Am Chem Soc. 1971; 93(18):4634-5. DOI: 10.1021/ja00747a073. View

Roy U, Islam M, Nagao J, Iida H, Mahin A, Li M . Bactericidal activity of nukacin ISK-1: an alternative mode of action. Biosci Biotechnol Biochem. 2014; 78(7):1270-3. DOI: 10.1080/09168451.2014.918485. View

10.

Lei J, Sun L, Huang S, Zhu C, Li P, He J . The antimicrobial peptides and their potential clinical applications. Am J Transl Res. 2019; 11(7):3919-3931. PMC: 6684887. View

11.

Willey J, van der Donk W . Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol. 2007; 61:477-501. DOI: 10.1146/annurev.micro.61.080706.093501. View

12.

Garcia A, Osapay G, Tran P, Yuan J, Selsted M . Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun. 2008; 76(12):5883-91. PMC: 2583559. DOI: 10.1128/IAI.01100-08. View

13.

Parthasarathy S, Shah S, Raja Sager A, Rangan A, Durugu S . Staphylococcus lugdunensis: Review of Epidemiology, Complications, and Treatment. Cureus. 2020; 12(6):e8801. PMC: 7325404. DOI: 10.7759/cureus.8801. View

14.

Faber C, Hoogendoorn R, Stallmann H, Lyaruu D, van Nieuw Amerongen A, Wuisman P . In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model. J Antimicrob Chemother. 2004; 54(6):1078-84. DOI: 10.1093/jac/dkh441. View

15.

Jia Z, He M, Wang C, Chen A, Zhang X, Xu J . Nisin reduces uterine inflammation in rats by modulating concentrations of pro- and anti-inflammatory cytokines. Am J Reprod Immunol. 2019; 81(5):e13096. DOI: 10.1111/aji.13096. View

16.

Nguyen L, Haney E, Vogel H . The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011; 29(9):464-72. DOI: 10.1016/j.tibtech.2011.05.001. View

17.

Natsis N, Cohen P . Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections. Am J Clin Dermatol. 2018; 19(5):671-677. DOI: 10.1007/s40257-018-0362-9. View

18.

Huang D, Parker D, Mandell J, Brothers K, Gish C, Koch J . Prospective Activity of PLG0206, an Engineered Antimicrobial Peptide, on Chronic Periprosthetic Joint Infection Total Knee Arthroplasty Components : The Knee Explant Analysis (KnEA) Study. Microbiol Spectr. 2021; 9(3):e0187921. PMC: 8612143. DOI: 10.1128/Spectrum.01879-21. View

19.

Raja Z, Andre S, Abbassi F, Humblot V, Lequin O, Bouceba T . Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent. PLoS One. 2017; 12(3):e0174024. PMC: 5358776. DOI: 10.1371/journal.pone.0174024. View

20.

Noore J, Noore A, Li B . Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus. Antimicrob Agents Chemother. 2013; 57(3):1283-90. PMC: 3591932. DOI: 10.1128/AAC.01650-12. View